What are Ultragenyx Pharmaceutical's profit margins?

Ultragenyx Pharmaceutical (RARE) runs a 97.2% gross margin and a -83.8% operating margin, with a -90.9% net margin.

Where do Ultragenyx Pharmaceutical's ratios come from?

Every ratio is computed from Ultragenyx Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Ultragenyx Pharmaceutical RARE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-83.8%-4.2pp	-79.5%+6.8pp	-86.4%-3.5pp	-82.9%+4.2pp	-87%+8.7pp
Net margin	-90.9%-5.5pp	-85.5%+6.5pp	-92%-4.6pp	-87.4%+5.7pp	-93.1%+8.5pp
EBITDA margin	-78.7%-4.4pp	-74.3%+6.3pp	-80.7%-3.7pp	-77%+3.9pp	-80.9%+8.4pp
Free cash flow margin	-75.1%-4.9pp	-70.2%+1.4pp	-71.5%-1.6pp	-70%-3.2pp	-66.8%+8.4pp
Returns
Return on assets	-46.7%-8.8pp	-37.9%+4.6pp	-42.5%-6.1pp	-36.4%+5.5pp	-41.9%-3.9pp
Efficiency
Asset turnover	0.5×+0.1×	0.4×0.0×	0.5×0.0×	0.4×0.0×	0.5×+0.1×
Liquidity
Current ratio	2×-0.5×	2.5×+0.6×	1.9×-0.6×	2.5×+0.1×	2.4×0.0×
Quick ratio	1.9×-0.5×	2.3×+0.6×	1.7×-0.6×	2.3×+0.1×	2.2×0.0×
Cash ratio	0.5×-0.6×	1.1×+0.5×	0.6×0.0×	0.6×+0.2×	0.4×-0.1×
Per Share
Book value per share	-$2.35-189%	-$0.81-984%	$0.09-94.0%	$1.54+2.8%	$1.50-46.9%
Valuation
Market capitalization	$2.06B-7.2%	$2.22B-23.5%	$2.9B-17.5%	$3.51B+3.3%	$3.4B-12.5%
Price / sales	3.1×-0.2×	3.3×-1.3×	4.6×-1.2×	5.8×0.0×	5.8×-1.2×
Free cash flow yield	-24.4%-3.1pp	-21.3%-5.7pp	-15.5%-3.4pp	-12.1%-0.6pp	-11.6%-0.8pp
Earnings yield	-29.6%-3.7pp	-25.9%-5.9pp	-20%-4.8pp	-15.2%+1.0pp	-16.2%-1.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ultragenyx Pharmaceutical's profit margins?: Ultragenyx Pharmaceutical (RARE) runs a 97.2% gross margin and a -83.8% operating margin, with a -90.9% net margin.
Where do Ultragenyx Pharmaceutical's ratios come from?: Every ratio is computed from Ultragenyx Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.